^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Title:

Response of Head and Neck Squamous Cell Carcinoma Cells Carrying PIK3CA Mutations to Select Targeted Therapies

Excerpt:
...treatment with GDC-0941 also revealed a relative resistance in PI3K-mutant carrying cells.
DOI:
10.1001/jamaoto.2015.0471